Hello, everyone, and how are you today? Another fine morning is unfolding over the ever-busy Pharmalot corporate campus, where the featured action today involves the mascots yapping at unknown passersby. We pay them no mind and return to our piping hot cup of stimulation, as well as our impressive to-do list, which includes a key meeting about our website. Stay tuned. Meanwhile, here a few items of interest. Hope your day goes well and you accomplish much...
Human Genome Lays Off 97 Employees (Baltimore Business Journal)
Some Parents Misunderstand Pediatric Cancer Trials (Reuters)
Congress Asks FDA For Reports Tied To Meningitis Outbreak (Bloomberg News)
Teva Cuts 65 Plant Jobs (Orange County Business Journal)
Ben Venue Restarts Limited Production (Outsourcing Pharma)
FDA Panel Backs Aegerion Cholesterol Drug (Bloomberg News)
Merck And Theravance Sign Cardiovascular Pact (Pharma Times)
AstraZeneca Signs Deal With Charles River Labs (Boston Business Journal)
Covagen Signs Biologics Deal With Mitsubishi Tanabe (Pharma Times)
DEA Crackdown On Painkillers Felt By Distributors (New York Times)
Actelion's Key Drug Halves Risk Of Deaths: Study (Bloomberg News)
Pfizer Renal Cell Carcinoma Drug Misses Endpoint (Dow Jones)
Merck KGgA Gets SPA For Pancreatic Cancer Trial (PharmaBiz)
Drugmaker Not Liable For Teen Overdose On Stolen Pills (NJ.com)
Mexico's Nealpharma Buys Pfizer Plant In Puerto Rico (SME Times)
Mylan Buying Plant In India (Pittsburgh Tribune-Review)
Multivitamins May Lower Cancer Risk In Men (Associated Press)
EDITOR'S NOTE: Please check this post for updates
morning coffee pic thx to chichacha on flickr
1 Comment
It's just no good to try to close the barn door after the horse is out.